TrialJournal of the European Academy of Dermatology and Venereology : JEADV2026

Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial.

Tadashi Terui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.